Search Results - "Deppisch, R"

Refine Results
  1. 1

    Low-GDP fluid (Gambrosol trio®) attenuates decline of residual renal function in PD patients: a prospective randomized study by Haag-Weber, Marianne, Krämer, Rosemarie, Haake, Rüdiger, Islam, Mohamed Shariful, Prischl, Friedrich, Haug, Ulrike, Nabut, José L., Deppisch, Reinhold

    Published in Nephrology, dialysis, transplantation (01-07-2010)
    “…Background. Residual renal function (RRF) impacts outcome of peritoneal dialysis (PD) patients. Some PD fluids contain glucose degradation products (GDPs)…”
    Get full text
    Journal Article
  2. 2

    Elimination of middle-sized uremic solutes with high-flux and high-cut-off membranes: a randomized in vivo study by Kneis, C, Beck, W, Boenisch, O, Klefisch, F, Deppisch, R, Zickler, D, Schindler, R

    Published in Blood purification (01-01-2013)
    “…The elimination of substances between 10 and 50 kDa by conventional high-flux membranes is not satisfactory. We investigated in vivo the elimination of…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Uremic toxicity: present state of the art by Vanholder, R, Argilés, A, Baurmeister, U, Brunet, P, Clark, W, Cohen, G, De Deyn, P P, Deppisch, R, Descamps-Latscha, B, Henle, T, Jorres, A, Massy, Z A, Rodriguez, M, Stegmayr, B, Stenvinkel, P, Wratten, M L

    Published in International journal of artificial organs (01-10-2001)
    “…The uremic syndrome is a complex mixture of organ dysfunctions, which is attributed to the retention of a myriad of compounds that under normal condition are…”
    Get full text
    Journal Article
  5. 5

    Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure by Müller-Krebs, S., Kihm, L. P., Zeier, B., Gross, M. L., Deppisch, R., Wieslander, A., Henle, T., Penndorf, I., Oh, J., Reiser, J., Nawroth, P. P., Zeier, M., Schwenger, V.

    Published in European journal of clinical investigation (01-05-2008)
    “…ABSTRACT Background  In peritoneal dialysis (PD) residual renal function contributes to improved patient survival and quality of life. Glucose degradation…”
    Get full text
    Journal Article
  6. 6

    Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis by HOFFMANN, J. N, HARTL, W. H, DEPPISCH, R, FAIST, E, JOCHUM, M, INTHORN, D

    Published in Intensive care medicine (01-12-1996)
    “…To determine whether hemofiltration (HF) can eliminate cytokines and complement components and alter systemic hemodynamics in patients with severe sepsis…”
    Get full text
    Journal Article
  7. 7

    Blood material interactions at the surfaces of membranes in medical applications by Deppisch, R., Storr, M., Buck, R., Göhl, H.

    Published in Separation and purification technology (27-08-1998)
    “…Membrane based medical therapies have increased considerably in recent years. At the same time, awareness of the side-effects caused by blood material…”
    Get full text
    Journal Article
  8. 8

    Complement components as uremic toxins and their potential role as mediators of microinflammation by Deppisch, Reinhold M., Beck, Werner, Goehl, Hermann, Ritz, Eberhard

    Published in Kidney international (01-02-2001)
    “…Complement components as uremic toxins and their potential role as mediators of microinflammation. Cardiovascular disease is the major cause of death in…”
    Get full text
    Journal Article
  9. 9

    Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility? by Ritz, E, Deppisch, R, Stier, E, Hänsch, G

    “…Cardiac events are a major cause of death in dialysed patients. This is due, at least in part, to the high prevalence of atherosclerotic coronary heart…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12

    Polymeric Membranes for Medical Applications by Krause, B., Storr, M., Ertl, T., Buck, R., Hildwein, H., Deppisch, R., Göhl, H.

    Published in Chemie ingenieur technik (14-11-2003)
    “…The commercial application of membranes in dialysis treatment has started already 40 years ago. Today, dialysis is the application in medicine using the…”
    Get full text
    Journal Article
  13. 13
  14. 14

    In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis by Wieslander, A P, Deppisch, R, Svensson, E, Forsbäck, G, Speidel, R, Rippe, B

    Published in Peritoneal dialysis international (1995)
    “…The aim of this study was to investigate a peritoneal dialysis (PD) fluid (PD-Bio), produced with the intention of reducing the amount of glucose degradation…”
    Get more information
    Journal Article
  15. 15

    Increased reduction of dimethylarginines and lowered interdialytic blood pressure by the use of biocompatible membranes by Schröder, Matthias, Riedel, Eberhard, Beck, Werner, Deppisch, Reinhold M., Pommer, Wolfgang

    Published in Kidney international (01-02-2001)
    “…Increased reduction of dimethylarginines and lowered interdialytic blood pressure by the use of biocompatible membranes. Hypertension contributes to cardiac…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Impact of membrane choice and blood flow pattern on coagulation and heparin requirement : potential consequences on lipid concentrations by SPERSCHNEIDER, H, DEPPISCH, R, BECK, W, WOLF, H, STEIN, G

    Published in Nephrology, dialysis, transplantation (01-12-1997)
    “…We reasoned that procoagulant activity, and by implication heparin requirement, during haemodialysis are influenced, amongst other factors, by the type of…”
    Get full text
    Journal Article
  18. 18

    Immunological determination of advanced glycosylation end-products in human blood and urine by Dolhofer-Bliesener, R, Lechner, B, Deppisch, R, Ritz, E, Gerbitz, K D

    Published in Nephrology, dialysis, transplantation (01-01-1995)
    “…Advanced glycosylation end-products (AGE) in human blood and urine were investigated with the aid of an AGE-specific enzyme-linked immunosorbent assay…”
    Get more information
    Journal Article
  19. 19

    Fluid phase generation of terminal complement complex as a novel index of bioincompatibility by Deppisch, Reinhold, Schmitt, Vera, Bommer, Jürgen, Hänsch, Gertrud M., Ritz, Eberhard, Rauterberg, Ernst Wilhard

    Published in Kidney international (01-02-1990)
    “…Fluid phase generation of terminal complement complex as a novel index of bioincompatibility. Blood membrane interactions in hemodialysis have been shown to…”
    Get full text
    Journal Article
  20. 20